Air Next

NuvoAir’s Air Next Spirometer Is FDA-Approved for In-Home Use

Retrieved on: 
Tuesday, January 30, 2024
Medical Devices, FDA, Hospitals, Health Technology, Telemedicine, Virtual Medicine, Cardiology, Biotechnology, Health, General Health, Spirometry, Travel, Heart, MD, Atmosphere of Earth, Asthma, Patient, Next, Clinical trial, Air Next, COPD, ATS, ALS, Medical device

Today, NuvoAir Medical announced its innovative Air Next Spirometer has received formal 510(k) clearance for in-home use as a full spirometer.

Key Points: 
  • Today, NuvoAir Medical announced its innovative Air Next Spirometer has received formal 510(k) clearance for in-home use as a full spirometer.
  • 510(k) approval empowers NuvoAir to scale and expand clinical operations to ensure no patient with heart or lung conditions is left behind.
  • 510(k) clearance allows Air Next to conduct full spirometry at home, providing extremely valuable clinical data that ensures patients can be monitored continuously.
  • “Air Next brings the reliability of in-clinic spirometry right to our patients’ hands,” says Furat Shawki, General Manager of Clinical Trials at NuvoAir.

NuvoAir US COPD Pilot Demonstrates Strong Patient Engagement, a Reduction in Hospitalizations, and Improved Quality of Life

Retrieved on: 
Thursday, August 18, 2022
People, Death, Biomarker, Risk, Health education, Air Next, United Kingdom, Algorithm, Population, Technology, Spirometry, American Lung Association, AHIP, Chronic obstructive pulmonary disease, Oxygen saturation (medicine), Quality of life, Patient, Mark (given name), AOS, Reading, MPH, National Health Service, Protocol, MBA, NHS, MD, Heart, Medical device, Pharmaceutical industry, Medicine, Medical imaging, Medicare, COPD

Initial data demonstrate the value of NuvoAir's virtual-first clinical service to effectively engage patients, reduce hospitalizations, and improve quality of life.

Key Points: 
  • Initial data demonstrate the value of NuvoAir's virtual-first clinical service to effectively engage patients, reduce hospitalizations, and improve quality of life.
  • NuvoAir aims to address key challenges in COPD care by marrying technology and human touch, resulting in the delivery of continuous and proactive care.
  • Applying leading guidelines to algorithms, NuvoAir's clinical teams analyze results and tailor care for each patient.
  • Of patients surveyed, 80% reported fewer COPD-related hospitalizations after enrolling, 60% reported fewer exacerbations, and 87% reported improved quality of life.

NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment

Retrieved on: 
Wednesday, May 25, 2022
Biotechnology, Medical Devices, Hospitals, Health, Clinical Trials, NHS, Spirometry, Death, Attack, Ageing, NHS trust, Asthma, Multimedia, Patient, Degenerative disease, COPD, University Hospitals of Leicester NHS Trust, Solution, University Hospitals Cleveland Medical Center, Portsmouth Hospitals University NHS Trust, Awareness, Mortality, Lancet, Royal Brompton Hospital, Colchester Hospital University NHS Foundation Trust, AOS, Air Next, COVID, Diagnosis, CEO, Hospital, Pharmaceutical industry

View the full release here: https://www.businesswire.com/news/home/20220523005860/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220523005860/en/
    Since 2017, NuvoAir has worked with over 40 NHS trusts, enabling NHS services to manage nearly 5,000 respiratory patients.
  • May is Asthma Awareness Month and efforts are underway to educate the public on the status of asthma in the UK, where asthma deaths are amongst the worst in Europe.
  • The NuvoAir Asthma Service will potentially improve access to this aspect of asthma care for people with asthma, leading to fewer asthma symptoms and attacks, says Professor Peter Bradding from University Hospitals of Leicester NHS Trust.
  • NuvoAir Founder and CEO, Lorenzo Consoli shares, We are excited to partner with the NHS and forward-looking clinicians to redesign new care pathways for people with asthma.